Literature DB >> 2882838

Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.

I Creese, E J Hess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2882838

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  4 in total

1.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.

Authors:  M S Lidow; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 2.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

4.  Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats.

Authors:  Roshni Baby Thomas; Shilpa Joy; M S Ajayan; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2013-08-22       Impact factor: 5.046
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.